Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Seth, Maliske"'
Autor:
Allison M. Bock, Jennifer J. Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema K. Tawfiq, Seth Maliske, Matthew J. Maurer, Brian F. Kabat, Jonas Paludo, David J. Inwards, Sabarish Ayyappan, Brian K. Link, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Umar Farooq, Yucai Wang
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Over the last two decades, the frontline therapy for mantle cell lymphoma (MCL) has evolved. However, the impact of subsequent lines of therapy on survival outcomes has not been well characterized. In this study, we investigated the treatmen
Externí odkaz:
https://doaj.org/article/ab1b048610ec4f4e949d375e8ba8630b
Autor:
Aung M. Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J. Inwards, Thomas M. Habermann, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Chimeric antigen receptor T-cell (CAR-T) therapy is the new standard of care in fit patients with refractory or early relapsed diffuse large B-cell lymphoma (DLBCL). However, there may still be a role for salvage chemotherapy (ST) and autologous stem
Externí odkaz:
https://doaj.org/article/46ad365a880749dfb154a7d75af7f42c
Autor:
Aung M. Tun, Seth Maliske, Yucai Wang, David J. Inwards, Thomas M. Habermann, Ivana Micallef, Luis Porrata, Jonas Paludo, Jose Villasboas Bisneto, Allison Rosenthal, Mohamed A Kharfan-Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston
Publikováno v:
Transplantation and Cellular Therapy. 28:610-617
Patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) who achieve progression-free survival (PFS) at 24 months (PFS24) after immunochemotherapy (IC) have excellent overall survival (OS) comparable to that of the age- and sex-matched gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e39fb7aee5e2ba50a7dd6c31de37e42
https://doi.org/10.1016/j.jtct.2022.06.015
https://doi.org/10.1016/j.jtct.2022.06.015
Autor:
Nathan, Boyer, Rajesh, Gupta, Alex, Schevchuck, Vindhya, Hindnavis, Seth, Maliske, Mark, Sheldon, Douglas, Drachman, Yerem, Yeghiazarians
Publikováno v:
The Journal of invasive cardiology. 26(6)
Coronary artery aneurysm (CAA) is an uncommon clinical finding, with an incidence varying from 1.5%-4.9% in adults, and is usually considered a variant of coronary artery disease (CAD). CAA identified in the context of acute coronary syndrome (ACS) r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd51adedaddbaf42a759df36aee30e4f
https://pubmed.ncbi.nlm.nih.gov/25661771
https://pubmed.ncbi.nlm.nih.gov/25661771